YZYong-Liang Zhang

Yong-Liang Zhang

*This is an algorithmically generated author record based on publicly available information.

Yong-Liang Zhang has a total of 54 co-authors. Here are the top co-authors by number of shared publications:

  • Lingzhi Li

    Department of Pharmacy, Logistics University of Chinese People's Armed Police Forces, Tianjin, China

    5 shared publications
  • Ling-Zhi Li

    4 shared publications
  • Lingzhi Li

    Tianjin Key Laboratory for Prevention and Control of Occupational and Environmental Hazard, Tianjin, China

    3 shared publications
  • Yaxiao Li

    Department of Pharmacy, Logistics University of Chinese People's Armed Police Forces, Tianjin, China

    3 shared publications
  • Yuqiang Wu

    Department of Pharmacy, Logistics University of Chinese People's Armed Police Forces, Tianjin, China

    3 shared publications
  • Chaofeng Shi

    Department of Pharmacy, Logistics University of Chinese People's Armed Police Forces, Tianjin, China; Medical Team, Zhoukou Detachment of Chinese People's Armed Police Forces, Henan, China

    2 shared publications

Latest Publications

  • Euscaphic acid and Tormentic acid protect vascular endothelial cells against hypoxia-induced apoptosis via PI3K/AKT or ERK 1/2 signaling pathway

    by Chaofeng Shi, Zhengchao Li, Yuqiang Wu, Xia Li, Yaxiao Li, Jinxia Wei, JianYu Li, Yongliang Zhang, Lingzhi Li


  • Open Access

    Kaji-Ichigoside F1 and Rosamultin Protect Vascular Endothelial Cells against Hypoxia-Induced Apoptosis via the PI3K/AKT or ERK1/2 Signaling Pathway

    by Chaofeng Shi, Li Zhan, Yuqiang Wu, Zhengchao Li, Jianyu Li, Yaxiao Li, Jinxia Wei, Yongliang Zhang, Lingzhi Li

    As a pair of differential isomers, Kaji-ichigoside F1 and Rosamultin are both pentacyclic triterpenoids isolated from the subterranean root of Potentilla anserina L., a plant used in folk medicine in western China as antihypoxia and anti-inflammatory treatments. We demonstrated that Kaji-ichigoside F1 and Rosamultin effectively prevented hypoxia-induced apoptosis in vascular endothelial cells. We established a hypoxia model, using EA.hy926 cells, to further explore the mechanisms. Hypoxia promoted the phosphorylation of AKT, ERK1/2, and NF-κB. In hypoxic cells treated with Kaji-ichigoside F1, p-ERK1/2 and p-NF-κB levels were increased, while the level of p-AKT was decreased. Treatment with Rosamultin promoted phosphorylation of ERK1/2, NF-κB, and AKT in hypoxic cells. Following the addition of LY294002, the levels of p-AKT, p-ERK1/2, and p-NF-κB decreased significantly. Addition of PD98059 resulted in reduced levels of p-ERK1/2 and p-NF-κB, while p-AKT levels were increased. Pharmacodynamic analysis demonstrated that both LY294002 and PD98059 significantly inhibited the positive effects of Kaji-ichigoside F1 on cell viability during hypoxia, consistent with the results of hematoxylin-eosin (H&E) staining, DAPI staining, and flow cytometry. The antihypoxia effects of Rosamultin were remarkably inhibited by LY294002 but promoted by PD98059. In Kaji-ichigoside F1- and Rosamultin-treated cells, Bcl2 expression was significantly upregulated, while expression of Bax and cytochrome C and levels of cleaved caspase-9 and cleaved caspase-3 were reduced. Corresponding to pharmacodynamic analysis, LY294002 inhibited the regulatory effects of Kaji-ichigoside F1 and Rosamultin on the above molecules, while PD98059 inhibited the regulatory effects of Kaji-ichigoside F1 but enhanced the regulatory effects of Rosamultin. In conclusion, Kaji-ichigoside F1 protected vascular endothelial cells against hypoxia-induced apoptosis by activating the ERK1/2 signaling pathway, which positively regulated the NF-κB signaling pathway and negatively regulated the PI3K/AKT signaling pathway. Rosamultin protected vascular endothelial cells against hypoxia-induced apoptosis by activating the PI3K/AKT signaling pathway and positively regulating ERK1/2 and NF-κB signaling pathways.


  • Pharmacokinetics study of rosamultin, a major bioactive component from the root of Potentilla anserina L. (Rosaceae) by HPLC-MS/MS

    by Yuqiang Wu, Jinxia Wei, Yingying Yu, Fei Chen, Xia Li, Yaxiao Li, Jianyu Li, Lingzhi Li, Yongliang Zhang

    Rosamultin is a major active pentacyclic triterpenoid saponin isolated from the root of Potentilla anserina L., which has various pharmacological activities. So far, the pharmacokinetics of rosamultin have not been studied. Hence, the present study was aimed at the development of a high performance liquid chromatography-tandem mass spectrometry method to quantify the concentration of rosamultin in rat plasma for an in vivo pharmacokinetics study. Plasma samples were prepared by a simple protein precipitation and further purified by solid phase extraction. Kaji-ichigoside F1, an epimer of rosamultin, was chosen as the internal standard. Chromatographic separation was performed on a HPLC XB-C18 column (4.6 × 150 mm, i.d., 3 μm) with a mobile phase consisting of methanol–water–formic acid (63 : 37 : 0.075, v/v/v). Quantification was performed by selected ion monitoring with m/z 673.5 [M + Na]+ for rosamultin and the internal standard. The validated method exhibited good linearity over a wide concentration range (r > 0.9995), and the lower limit of quantification was as low as 5.0 ng mL−1 for rosamultin. The intra- and inter-day precisions (RSD) at all quality control (QC) levels ranged from 3.4–7.7% and 4.3–7.2%, respectively. The accuracy (RE) was from 2.5% to 5.3%. The developed method was rapid, accurate, sensitive and fully validated. It was successfully applied to the pharmacokinetics study of rosamultin in rats after oral administration of rosamultin.


  • Open Access

    Expression profile of plasma microRNAs and their roles in diagnosis of mild to severe traumatic brain injury

    by Xiaojing Qin, Lingzhi Li, Qi Lv, Qingming Shu, Yongliang Zhang, Yaping Wang

    Traumatic brain injury (TBI) is associated with trauma-related death. In this study, we evaluated differences in the expression of plasma microRNAs (miRNAs) in patients with different degrees of TBI, and explored the potential of miRNAs for use as diagnostic TBI biomarkers. The miRNA microarray results showed upregulation of 65, 33, and 16 miRNAs and downregulation of 29, 27, and 6 miRNAs in patients with mild, moderate, and severe TBI, respectively, compared with healthy controls. Thirteen miRNAs (seven upregulated and six downregulated) were found to be present in all TBI groups. Seven upregulated miRNAs were selected for validation in an enlarged cohort of samples and showed good diagnostic accuracy. The expression levels of miR-3195 and miR-328-5p were higher in the severe TBI group than in the mild and moderate TBI groups. In summary, our study demonstrates different expression profiles in plasma miRNAs among patients with mild to severe TBI. A subset of seven miRNAs can be used for diagnosis of TBI. Moreover, miR-3195 and miR-328-5p may be utilized during diagnosis to distinguish mild and moderate TBI from severe TBI.


  • Open Access

    Protective Effect of Rosamultin against H2O2‐Induced Oxidative Stress and Apoptosis in H9c2 Cardiomyocytes

    by Ling Zhang, Yang Liu, Jian Yu Li, Ling Zhi Li, Yong Liang Zhang, Hai Ying Gong, Ying Cui

    Rosamultin is one of the main active compounds isolated from Potentilla anserina L., which belongs to a triterpene compound. Few studies have examined the effect of rosamultin on oxidative stress and its molecular mechanism. The aim of this present study was to elucidate the protective effect of rosamultin on H2O2‐induced oxidative damage and apoptosis in H9c2 cardiomyocytes and its mechanism. The results showed that the pretreatment of rosamultin not only increased cell viability but also reduced the release of LDH and CK. Rosamultin inhibited a H2O2‐induced decrease in SOD, CAT, and GSH‐Px activities and an increase in MDA content. Meanwhile, ROS level, intracellular (Ca2+) fluorescence intensity, and apoptosis rate in the rosamultin pretreated group were markedly decreased compared with the model group. Rosamultin pretreatment significantly reversed the morphological changes and attenuated H2O2‐induced apoptosis. Western blot analysis showed that rosamultin enhanced the expression of Bcl‐2 and pCryAB and downregulated the expression of Bax, Cyt‐c, Caspase‐3, and Caspase‐9 expression. Additionally, rosamultin might activate PI3K/Akt signal pathways and CryAB relative factors. Therefore, we suggest that rosamultin could have the potential for treating H2O2‐induced oxidative stress injury through its antioxidant and antiapoptosis effect.


  • Daidzein increases OPG/RANKL ratio and suppresses IL-6 in MG-63 osteoblast cells

    by Jing Sun, Wei Jia Sun, Zheng Yang Li, Ling Li, Yue Wang, Yu Zhao, Cong Wang, Li Ren Yu, Ling Zhi Li, Yong Liang Zhang


  • Open Access

    Sequential expression of cyclooxygenase-2, glutamate receptor-2, and platelet activating factor receptor in rat hippocampal neurons after fluid percussion injury

    by Yongliang Zhang, Zhiqiang Li, Qingming Shu, Lingzhi Li, Maolin Ge

    Traumatic brain injury causes gene expression changes in different brain regions. Occurrence and development of traumatic brain injury are closely related, involving expression of three factors, namely cyclooxygenase-2, glutamate receptor-2, and platelet activating factor receptor. However, little is known about the correlation of these three factors and brain neuronal injury. In this study, primary cultured rat hippocampal neurons were subjected to fluid percussion injury according to Scott's method, with some modifications. RT-PCR and semi-quantitative immunocytochemical staining was used to measure the expression levels of cyclooxygenase-2, glutamate receptor-2, and platelet activating factor receptor. Our results found that cyclooxygenase-2 expression were firstly increased post-injury, and then decreased. Both mRNA and protein expression levels reached peaks at 8 and 12 hours post-injury, respectively. Similar sequential changes in glutamate receptor 2 were observed, with highest levels mRNA and protein expression at 8 and 12 hours post-injury respectively. On the contrary, the expressions of platelet activating factor receptor were firstly decreased post-injury, and then increased. Both mRNA and protein expression levels reached the lowest levels at 8 and 12 hours post-injury, respectively. Totally, our findings suggest that these three factors are involved in occurrence and development of hippocampal neuronal injury.


  • Open Access

    Cytokines expression profiling as a window into hypoxia SH-SY5Y cells treated with N-butyl extract of Potentilla anserina L.

    by Hong-Sheng Gao, Hui-Min Guo, Yi-Zheng Wang, Hong Chen, Yong-Liang Zhang, Ling-Zhi Li, Jing Sun

    Potentilla anserina L. is the root of Chinese cinquefoil herb of the Rosaceae family, and its ethanol extract improves the immunity and exhibits anti-fatigue and anti-hypoxia properties. This study aimed to explore the cytokines expression profiling and the effect of n-butanol extract of P. anserina L. (NP) on the hypoxia cells. The subjects were divided into three groups: control, hypoxia, and intervention (the group treated with the n-butyl extract of P. anserina L. under the condition of hypobaric hypoxia) groups. The results of the experiment showed that NP could down-regulate the expression of the proinflammatory cytokines of hypoxia SH-SY5Y cells and meantime up-regulate the expression of inhibitive cytokines of immune reaction. The cytokines expression profiling can be deduced as a window into hypoxia SH-SY5Y cells, and n-butyl extract of P. anserina L. can significantly protect the cell against the hypoxia induced damage set up in vitro by sodium dithionite. Key words: Hypoxia, inflammatory cytokines, Potentilla anserina L., sodium dithionite.


    • 1 May 2012
      • Vol. 37  (9) , 1279-84

    [Study on protective effect of alcohol extract of Potentilla Anserinea against acute myocardial ischemia/reperfusion-induced myocardial apoptosis in rats].

    by Xiaojing Qin, Qi Lv, Xinning Zhang, Fuquan Chen, Lingzhi Li, Yongliang Zhang

    To observe the protective effect of alcohol extract of Potentilla anserina against myocardial apoptosis induced by acute myocardial ischemia/reperfusion by arteria coronaria ligation and the effect on the expressions of Caspase-3 and Caspase-9 in myocardial apoptosis signal pathway. Male SD rats were randomly divided into the sham-operated group, the model group, the diltiazem group (30 mg x kg(-1)) and P. anserine alcohol extract intervention groups (0.9, 1.8, 3.6 g x kg(-1)). Rat acute myocardial ischemia/reperfusion model was established by ligating left anterior descending. Apoptosis of myocardial cells were detected by TUNEL (Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling assay). The expressions of Caspase-3 and Caspase-9 mRNA were assayed by reverse transcription-polymerase chain reaction (RT-PCR). Semi-quantitative analysis was made for the expressions of Caspase-3 and Caspase-9 by immunohistochemistry. According to TUNEL results, after I/R injury-induced myocardial apoptosis, the apoptotic index (AI) of model group was (31.5 +/- 3.6)%. All P. anserine alcohol extract intervention groups showed obvious inhibition of ischemia/reperfusion-induced myocardial apoptosis. In the model group, myocardial apoptosis caused increased expression of Caspase-3, Caspase-9 mRNA and proteins. After the administration of P. anserine alcohol extract, 1.8, 3.6 g x kg(-1) dose groups showed notable decrease in Caspase-9 mRNA (P < 0.05), while the 0.9 g x kg(-1) dose group showed no significant difference with the model group. Alcohol extract of P. anserina in all dosages showed inhibitory effect on the expression of Caspase-3 mRNA in myocardial cells compared with model group (P < 0.05). Immunohistochemistry showed that administration of all dosages of alcohol extract of P. anserina could significantly reduce Caspase-3 and Caspase-9 protein expressions after I/R injury (P < 0.05). The administration with alcohol extract of P. anserina can protect the myocardial tissue from apoptosis after acute myocardial ischemia and reperfusion injury in rats and inhibit the expressions of Caspase-9 and Caspase-3 mRNA and proteins.